Antiemetic Agents Children
should be used with caution in children who are at higher risk for adverse effects, including CNS effects and fluid and electrolyte disturbances. Targeting the trigger causing the nausea and vomiting may be the best treatment strategy in many instances.
Antiemetic Agents Adults
often used after surgery or chemotherapy, and precautions should be used to ensure that CNS effects do not interfere with mobility or other activities.
The safety of these drugs during pregnancy and lactation has not been established.
Antiemetics Older Adults
likely to develop adverse effects associated with the use of these drugs, including sedation, confusion, dizziness, fluid imbalance, and CV effects.
Safety measures may be needed if these effects occur and interfere with the patient’s mobility and balance.
Antiemetic Agents
Used for nausea and vomiting
All of them work by reducing the hyperactivity of the vomiting reflex in one of two ways: locally, to decrease the local response to stimuli that are being sent to the medulla to induce vomiting, or centrally, to block the chemoreceptor trigger zone (CTZ) or suppress the vomiting center directly.
Chlorpromazine
Treatmentt of nausea and vomitng assoicated with anesthesia, hiccougth
Treatment of schizophrenia and other psychosis, mania, anxiety
Perhapenazine
Treatment of severe nausea and vomting
Intractable hiccough in patients .12 years
Psychiatric symptoms
Proclorperazine
Treatment and prevention of nausea, vomiting and motion sickness
Treamtent of allergic and Vasomotor rhinitis , allergic conjunctivitis, mild allergic skin manifestations, procedural sedation
Metoclopramide: Nonphenothiazine
Treatment of GERD
Preventions of nausea and vomiting
Works by blocking dopamines reception and making hte GI cells more sensitive I to acetylcholine, which leads to increased GI activity and rapid movement through the upper GI tract
5-HT3 Recpetor Blockers
receptor blockers block those receptors associated with nausea and vomiting in the CTZ and locally.
helpful in treating the nausea and vomiting associated with antineoplastic chemotherapy and radiation therapy and postoperative nausea and vomiting.
Used in both adults and children
Phenothiazines
Centrally acting antiemetics that change the responsiveness or stimulation of the CTZ in the medulla.
Most work as dopamine antagonists which can be used for treatment of some psychiatric diagnoses.
Phenothiazines Indications
recommended for the treatment of nausea and vomiting, including that specifically associated with anesthesia, severe vomiting, and intractable hiccoughs, which occur with repetitive stimulation of the diaphragm and lead to persistent diaphragm spasm.
Phenothiazines Contraindications
antiemetics should not be used in patients with coma or severe central nervous system (CNS) depression or in those who have experienced brain damage or injury because of the risk of further CNS depression.
Other: include severe hypotension or hypertension and severe liver dysfunction, which might interfere with the metabolism of the drug.
Phenothiazines Adverse Effects
linked to their interference with normal CNS stimulation or response.
Drowsiness, dizziness, weakness, tremor, and headache are common adverse effects.
Other: hypotension and cardiac arrhythmias. Autonomic effects such as dry mouth, nasal congestion, anorexia, pallor, sweating, and urinary retention often occur with phenothiazines
5-Ht3 Receptor Blockers Adverse Effects
headache, dizziness, and myalgia related to their CNS effects.
Pain at the injection site, rash, constipation, diarrhea, hypotension, and urinary retention have also been reported.
Substance P/Neurokin 1 Receptor Antagonist
Drugs act directly in the CNS to block receptors associated with nausea and vomiting with little to no effect on serotonin, dopamine, or corticosteroid receptors.
They have been found to work synergistically with serotonin antagonists and dexamethasone to prevent nausea and vomiting associated with chemotherapy.
Aprepitant: Substance P/Neurokinin 1 Receptor Antagonist
In combination with other agents for the prevention of acute and delayed nausea and vomiting associated with severely emetogenic cancer chemotherapy.
Selectively blocks human substance P/NK1 receptors in the CNS, blocking the nausea and vomiting caused by highly emetogenic chemotherapeutic agents.
Aprepitant: Substance P/Neurokinin 1 Receptor Antagonist Adverse Affects
Anorexia, fatigue, constipation, diarrhea, liver enzyme elevations, dehydration.